KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.
about
Allosteric regulation of epigenetic modifying enzymes.The involvement of histone methylation in osteoblastic differentiation of human periosteum-derived cells cultured in vitro under hypoxic conditions.Runt-Related Transcription Factor 2 Induction During Differentiation of Wharton's Jelly Mesenchymal Stem Cells to Osteoblasts Is Regulated by Jumonji AT-Rich Interactive Domain 1B Histone Demethylase.TNF-α inhibits SATB2 expression and osteoblast differentiation through NF-κB and MAPK pathways.Effects of new beta-type Ti-40Nb implant materials, brain-derived neurotrophic factor, acetylcholine and nicotine on human mesenchymal stem cells of osteoporotic and non osteoporotic donors.
P2860
KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KDM5A controls bone morphogeni ...... tem cells during osteoporosis.
@en
KDM5A controls bone morphogeni ...... tem cells during osteoporosis.
@nl
type
label
KDM5A controls bone morphogeni ...... tem cells during osteoporosis.
@en
KDM5A controls bone morphogeni ...... tem cells during osteoporosis.
@nl
prefLabel
KDM5A controls bone morphogeni ...... tem cells during osteoporosis.
@en
KDM5A controls bone morphogeni ...... tem cells during osteoporosis.
@nl
P2093
P2860
P356
P1476
KDM5A controls bone morphogeni ...... stem cells during osteoporosis
@en
P2093
Chuandong Wang
Qingfeng Li
Shengzhou Shan
P2860
P356
10.1038/CDDIS.2016.238
P577
2016-08-11T00:00:00Z